Nanoparticle vaccine for COVID-19 spurs robust immune response in preclinical tests
September 21, 2020 - Scripps Research, La Jolla, CA In a new study that demonstrates the promise of a novel vaccine approach for COVID-19, Scripps Research scientist Jiang Zhu, PhD, showed that his protein nanoparticle technology successfully triggered a strong immune response in mice. Zhu, [...]
Researchers unveil promising hepatitis C vaccine design
April 15, 2020 - Scripps Research, La Jolla, CA A new design for a vaccine against hepatitis C virus (HCV) has shown promise in early tests, according to a study from scientists at Scripps Research. The scientists, who present their results on April 15 in [...]
cGMP Process Kickoff Meeting
March 25, 2019 - NIH Division of AIDS (DAIDS), ABL Inc, Ufovax Inc and Dr. Zhu (on behalf of Scripps Research) held a kickoff meeting to start the cGMP process development for the HIV-1 nanoparticle vaccines developed in Dr. Zhu's laboratory.
UFOVAX and Scripps Research Sign 5 Year Agreement
February 14, 2019 - Ufovax Inc signed a five-year agreement with Scripps Research to support vaccine development in Dr. Zhu's laboratory.
Scripps Research scientists unveil promising new HIV vaccine strategy
November 26, 2018 LA JOLLA, CA – A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests. The new vaccine strategy, described in a paper on November 23 in [...]
TSRI Scientists Stabilize HIV Structure, Design Potential AIDS Vaccine Candidates
Findings Represent ‘Big Accomplishment’ in Biomedical Engineering and Design LA JOLLA, CA – June 28, 2016 – Want to catch a criminal? Show a mugshot on the news. Want to stop HIV infections? Get the immune system to recognize and attack the virus’s tell-tale structure. [...]